Role of FBXO45 in Diffuse Large B Cell Lymphoma Pathogenesis
Role of FBXO45 in Diffuse Large B Cell Lymphoma Pathogenesis
批准号:
10412096
负责人:
KOJO S. J. ELENITOBA-JOHNSON
金额:
$2.49万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-07-03 至 2022-07-31
关键词:
3q29AffinityAffinity ChromatographyB cell differentiationB-Cell DevelopmentB-Cell LymphomasB-Lymphocyte SubsetsB-LymphocytesBCL2 geneBCL6 geneBiochemicalBiologicalBiological ProcessBirthCancer EtiologyCell Differentiation processCell LineCell physiologyCellsCellular biologyCessation of lifeCharacteristicsClustered Regularly Interspaced Short Palindromic RepeatsCommunitiesComplementConstitutionalCullin ProteinsDataDevelopmentEventF Box DomainFamilyGene TargetingGenesGeneticGenomicsGrowthGuanine Nucleotide Exchange FactorsHourHumanKnock-inKnock-outLymphomaLymphomagenesisMS4A1 geneMalignant NeoplasmsMediatingMolecularMolecular Biology TechniquesMusMutagenesisNeoplasmsOncogenicPathogenesisPharmacologyPlayProteolysisProteomicsRNARNA InterferenceRecurrenceResearchResourcesRoleSamplingStructure of germinal center of lymph nodeTamoxifenTestingTimeTransgenic MiceTumor Suppressor GenesTumor Suppressor ProteinsTumorigenicityUbiquitin-mediated Proteolysis PathwayUpdateXenograft Modelcohortgenome sequencingin vivoinsightlarge cell Diffuse non-Hodgkin&aposs lymphomamembermouse modelnovelnovel therapeutic interventionprognosticproteogenomicsscreeningsmall hairpin RNAtandem mass spectrometrytargeted treatmenttreatment strategyubiquitin ligaseubiquitin-protein ligasewhole genome
中文摘要
项目摘要
FBXO 45在人大B细胞淋巴瘤发病中的作用
弥漫性大B细胞淋巴瘤(DLBCL)是一种侵袭性淋巴瘤,代表了
西半球最常见的恶性淋巴瘤。生物事件
DLBCL的潜在发病机制尚未完全了解。我们最近
鉴定了FBXO 45的功能失活,FBXO 45是DLBCL中的E3泛素连接酶。在这
应用中,我们将利用转基因小鼠模型来探索生物学作用,
FBXO 45在B细胞分化和淋巴瘤发生中的作用此外,我们将采用
生物化学和分子生物学技术,以更好地了解FBXO 45在
DLBCL的发病机制。因此,我们在本申请的第一个目的中提出利用
新创建的转基因小鼠模型,以功能性地询问FBXO 45在B-
细胞发育和淋巴瘤发生。在第二个目标中,我们将确定全球
FBXO 45在B细胞环境中的细胞底物。这些研究将确定
FBXO 45在DLBCL发病机制中的作用,并建立其作用机制。
放松管制有助于DLBCL。
英文摘要
PROJECT SUMMARY
THE ROLE OF FBXO45 IN DIFFUSE LARGE B-CELL LYMPHOMA PATHOGENESIS
Diffuse large B-cell lymphoma (DLBCL) is an aggressive lymphoma and represents the
most common form of malignant lymphoma in the western hemisphere. The biologic events
underlying the pathogenesis of DLBCL are not completely understood. We have recently
identified functional inactivation of FBXO45, an E3 ubiquitin ligase in DLBCL. In this
application, we will utilize transgenic mouse models to explore the biological roles for
FBXO45 in B-cell differentiation and lymphomagenesis. Further, we will employ
biochemical and molecular biology techniques to better understand the role FBXO45 in the
pathogenesis of DLBCL. Accordingly, we propose in the first aim of this application to utilize
newly created transgenic mouse models to functionally interrogate the role of FBXO45 in B-
cell development and lymphomagenesis. In the second aim, we will identify the global
cellular substrates of FBXO45 in B cell contexts. These studies will establish the role of
FBXO45 in the pathogenesis of DLBCL and establish the mechanisms by which its
deregulation contributes to DLBCL.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Role of FBXO45 in Diffuse Large B Cell Lymphoma Pathogenesis
-
批准号:10655478
-
项目类别:
-
资助金额:$53.08万
-
财政年份:2022
-
负责人:KOJO S. J. ELENITOBA-JOHNSON
-
依托单位:
Role of FBXO45 in Diffuse Large B Cell Lymphoma Pathogenesis
-
批准号:10703746
-
项目类别:
-
资助金额:$51.11万
-
财政年份:2022
-
负责人:KOJO S. J. ELENITOBA-JOHNSON
-
依托单位:
Genomic biomarkers of splenic lymphoma
-
批准号:10703846
-
项目类别:
-
资助金额:$19.45万
-
财政年份:2022
-
负责人:KOJO S. J. ELENITOBA-JOHNSON
-
依托单位:
Genomic biomarkers of splenic lymphoma
-
批准号:10531857
-
项目类别:
-
资助金额:$62.15万
-
财政年份:2022
-
负责人:KOJO S. J. ELENITOBA-JOHNSON
-
依托单位:
Epiproteomics of Sezary Syndrome
-
批准号:10406932
-
项目类别:
-
资助金额:$13.46万
-
财政年份:2020
-
负责人:KOJO S. J. ELENITOBA-JOHNSON
-
依托单位:
Epiproteomics of Sezary Syndrome
-
批准号:10031052
-
项目类别:
-
资助金额:$61.04万
-
财政年份:2020
-
负责人:KOJO S. J. ELENITOBA-JOHNSON
-
依托单位:
Epiproteomics of Sezary Syndrome
-
批准号:10703845
-
项目类别:
-
资助金额:$52.87万
-
财政年份:2020
-
负责人:KOJO S. J. ELENITOBA-JOHNSON
-
依托单位:
Epiproteomics of Sezary Syndrome
-
批准号:10632068
-
项目类别:
-
资助金额:$56.66万
-
财政年份:2020
-
负责人:KOJO S. J. ELENITOBA-JOHNSON
-
依托单位:
Genomic biomarkers of splenic lymphoma
-
批准号:10312006
-
项目类别:
-
资助金额:$41.22万
-
财政年份:2020
-
负责人:KOJO S. J. ELENITOBA-JOHNSON
-
依托单位:
Role of FBXO45 in Diffuse Large B Cell Lymphoma Pathogenesis
-
批准号:9817011
-
项目类别:
-
资助金额:$50.21万
-
财政年份:2019
-
负责人:KOJO S. J. ELENITOBA-JOHNSON
-
依托单位:
Role of FBXO45 in Diffuse Large B Cell Lymphoma Pathogenesis
-
批准号:10240270
-
项目类别:
-
资助金额:$47.33万
-
财政年份:2019
-
负责人:KOJO S. J. ELENITOBA-JOHNSON
-
依托单位:
Proteomic analysis of api2-MALT1 positive gastric MALT lymphoma
-
批准号:8215896
-
项目类别:
-
资助金额:$27.77万
-
财政年份:2009
-
负责人:KOJO S. J. ELENITOBA-JOHNSON
-
依托单位:
Proteomic analysis of api2-MALT1 positive gastric MALT lymphoma
-
批准号:7565662
-
项目类别:
-
资助金额:$28.92万
-
财政年份:2009
-
负责人:KOJO S. J. ELENITOBA-JOHNSON
-
依托单位:
Proteomic analysis of api2-MALT1 positive gastric MALT lymphoma
-
批准号:8035900
-
项目类别:
-
资助金额:$27.87万
-
财政年份:2009
-
负责人:KOJO S. J. ELENITOBA-JOHNSON
-
依托单位:
Proteomic analysis of api2-MALT1 positive gastric MALT lymphoma
-
批准号:8458901
-
项目类别:
-
资助金额:$26.01万
-
财政年份:2009
-
负责人:KOJO S. J. ELENITOBA-JOHNSON
-
依托单位:
Mass spectrometry-driven systems biologic analysis of salivary MALT lymphoma
-
批准号:7530780
-
项目类别:
-
资助金额:$38.63万
-
财政年份:2008
-
负责人:KOJO S. J. ELENITOBA-JOHNSON
-
依托单位:
Mass spectrometry-driven systems biologic analysis of salivary MALT lymphoma
-
批准号:7882577
-
项目类别:
-
资助金额:$38.24万
-
财政年份:2008
-
负责人:KOJO S. J. ELENITOBA-JOHNSON
-
依托单位:
Mass spectrometry-driven systems biologic analysis of salivary MALT lymphoma
-
批准号:7663159
-
项目类别:
-
资助金额:$38.63万
-
财政年份:2008
-
负责人:KOJO S. J. ELENITOBA-JOHNSON
-
依托单位:
Mass spectrometry-driven systems biologic analysis of salivary MALT lymphoma
-
批准号:8118856
-
项目类别:
-
资助金额:$37.09万
-
财政年份:2008
-
负责人:KOJO S. J. ELENITOBA-JOHNSON
-
依托单位:
Quantitative proteomic analysis of lymphoma transformation
-
批准号:7254275
-
项目类别:
-
资助金额:$28.03万
-
财政年份:2006
-
负责人:KOJO S. J. ELENITOBA-JOHNSON
-
依托单位:
海外基金